Treatment of Type II Gastric Carcinoid Tumors with Somatostatin Analogues
- 24 August 2000
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 343 (8) , 551-554
- https://doi.org/10.1056/nejm200008243430805
Abstract
Gastric carcinoid tumors are rare tumors that originate from gastric enterochromaffin-like cells in the oxyntic mucosa.1 There are three types of gastric carcinoid tumors: type I is associated with chronic atrophic gastritis, type II develops in patients with combined multiple endocrine neoplasia type 1 and the Zollinger–Ellison syndrome, and type III is sporadic.1 Although the pathogenesis of these tumors is not completely understood, hypergastrinemia has an important role in the development of types I and II.2 The multiple endocrine neoplasia type 1 gene locus may be involved in type II gastric carcinoid tumors.3,4This publication has 14 references indexed in Scilit:
- Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LARAlimentary Pharmacology & Therapeutics, 2000
- ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysisGastroenterology, 1999
- Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid SyndromeJournal of Clinical Oncology, 1999
- Multimodality treatment for gastric carcinoid tumor with liver metastasesAmerican Journal of Gastroenterology, 1998
- Slow-Release Lanreotide Treatment in Endocrine Gastrointestinal TumorsAmerican Journal of Gastroenterology, 1998
- The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoidsGastroenterology, 1997
- Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growthJournal of Clinical Endocrinology & Metabolism, 1996
- Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?Gastroenterology, 1993
- Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic studyGastroenterology, 1993
- Long-Acting Somatostatin (SMS 201-995) in the Management of Zollinger-Ellison SyndromePancreas, 1988